Praxis Precision Medicines Inc
(NAS:PRAX)
$
53.12
2.14 (4.2%)
Market Cap: 908.77 Mil
Enterprise Value: 668.17 Mil
PE Ratio: 0
PB Ratio: 3.07
GF Score: 42/100 - Praxis Precision Medicines Inc Extraordinary Shareholders Meeting TranscriptNov 06, 2023
- Praxis Precision Medicines Inc R&D Day TranscriptOct 02, 2023
- Praxis Precision Medicines Inc at Jefferies Healthcare Conference TranscriptJun 09, 2023
- Praxis Precision Medicines Inc at Needham Healthcare Conference (Virtual) TranscriptApr 17, 2023
- Praxis Precision Medicines Inc Essential1 Topline Results Call TranscriptMar 03, 2023
- Praxis Precision Medicines Inc at Citi Biopharma Co-Panel Day (Virtual) - Mood Disorders/Mental Health Panel TranscriptMay 18, 2022
- Praxis Precision Medicines Inc at Bank of America Healthcare Conference TranscriptMay 11, 2022
- Q1 2022 Praxis Precision Medicines Inc Earnings Call TranscriptMay 09, 2022$110.85 (-8.54%)Earnings
- Praxis Precision Medicines Inc Epilepsy Day TranscriptApr 27, 2022
- Praxis Precision Medicines Inc at Cowen Health Care Conference (Virtual) TranscriptMar 07, 2022
- Q4 2021 Praxis Precision Medicines Inc Earnings Call TranscriptFeb 28, 2022$196.5 (-1.73%)Earnings
- Praxis Precision Medicines Inc Movement Disorder Day TranscriptDec 17, 2021
- Q3 2021 Praxis Precision Medicines Inc Earnings Call TranscriptNov 03, 2021$329.55 (+1.24%)Earnings
- Praxis Precision Medicines Inc at Citi BioPharma Conference (Virtual) TranscriptSep 08, 2021
- Praxis Precision Medicines Inc Annual Shareholders Meeting TranscriptJun 08, 2021
- Q4 2020 Praxis Precision Medicines Inc Earnings Call TranscriptMar 17, 2021$637.65 (+2.56%)Earnings
Praxis Precision Medicines Inc at Bank of America Healthcare Conference Transcript
May 11, 2022 / 09:00PM GMT
Release Date Price:
$131.25
(-4.99%)
Tazeen Ahmad
BofA Securities, Research Division - MD in Equity Research & Research Analyst
Great. Good afternoon, everybody. Welcome back to the Bank of America Healthcare Conference day 2. I am Tazeen Ahmad. I'm one of the senior SMID biotech analysts here at the bank. It's my pleasure to have our next presenting company with us, Praxis Precision Medicines. Sitting next to me are Marcio Souza, who's President and CEO; as well as Bernard Ravina, who is the Chief Medical Officer. Gentlemen, good afternoon, and thank you for coming to Las Vegas.
Marcio Souza
Praxis Precision Medicines, Inc. - President, CEO & Director
Thank you. Thanks for having us.
Tazeen Ahmad;Marcio Souza
BofA Securities, Research Division - MD in Equity Research & Research Analyst;Praxis Precision
So maybe, Marcio, can we start with a quick overview of the company, maybe a 2-minute summary of your platform and some of the recent developments, and then we can go into some more detailed questions?
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)